Condition
Medications for Opioid Use Disorder
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Not Yet Recruiting2
Enrolling By Invitation1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06766331Not ApplicableNot Yet Recruiting
Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans
NCT07490717Not ApplicableEnrolling By Invitation
Developing and Testing Innovative Care Pathways for Screening and Treatment of OUD/PTSD in Jails
NCT06880718Phase 4Not Yet Recruiting
Injectable Buprenorphine in Prison: a Preference Trial
Showing all 3 trials